Skip to main content
Clinical Trials/NL-OMON55297
NL-OMON55297
Completed
Phase 3

The evaluation of the influence of the use of total blood volume measurement during dialysis on the incidence of intradialytic hypotension associated events - Total blood volume measurement in hemodialysis

HagaZiekenhuis0 sites59 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
HagaZiekenhuis
Enrollment
59
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

Trial is onging in other countries

Registry
who.int
Start Date
TBD
End Date
December 21, 2021
Last Updated
2 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • hemodialysis patients of three dialysis locations of the Haga Hospital
  • (Zoetermeer, The Hague Leyweg and The Hague Sportlaan).
  • \- Chronic hemodialysis patients in whom initiation of treatment predates
  • inclusion in the study by \>\= 3 months.
  • \- Hemodialysis scheme three times weekly for four hours (Monday \- Wednesday \-
  • Friday or Tuesday \- Thursday \- Saturday)
  • \- Age \>18 years.
  • \- Signed informed consent must be obtained prior to any study specific
  • procedures.

Exclusion Criteria

  • Clinically relevant fistula dysfunction resulting in spKtV \<1,2
  • Severe volume overload with a contraindication to bolus fluid infusion during
  • dialysis according to the treating physician.
  • Severe cardiac dysfunction responsible for \>1x intradialytic hypotension
  • associated adverse event /week according to treating physician
  • Severe liver failure with or without presence of ascites
  • More than three hemodialysis sessions per week
  • Single needle treatment
  • Central venous access
  • Residual diuresis

Outcomes

Primary Outcomes

Not specified

Similar Trials